Literature DB >> 604361

Granuloma formation in patients after injection of methanol extraction residue (MER-GCG).

A Bartal, H Kerner, Y Cohen, E Robinson.   

Abstract

Nine patients with advanced cancer who were receiving the methanol extraction residue of BCG (MER-BCG) intradermally or intratumorally underwent biopsies from the injected sites or from locally enlarged lymph nodes. Most preparations showed a chronic granulomatous reaction consisting of lymphocytes, histiocytes, and epithelioid cells as well as either Langhans's or foreignbody type giant cells, or both. The degree of granuloma formation and giant cell infiltration varied. In only one case did the reactions consist merely of chronic lymphocytic and histiocytic inflammation with no granuloma formation. Examination of melanoma nodules injected with MER showed, in addition to granulomas, large numbers of giant cells penetrating the tumour.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 604361      PMCID: PMC476699          DOI: 10.1136/jcp.30.12.1149

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Observations following Corynebacterium parvum administration to patients with advanced malignancy. a phase I study.

Authors:  B Fisher; H Rubin; G Sartiano; L Ennis; N Wolmark
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

Review 2.  BCG and cancer.

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-27       Impact factor: 91.245

3.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

4.  Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli.

Authors:  D W Weiss
Journal:  Natl Cancer Inst Monogr       Date:  1972-12

5.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

6.  Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.

Authors:  D L Granger; W Brehmer; W Brehmer; K Yamamoto; E Ribi
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

Review 7.  Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications.

Authors:  M S Mitchell
Journal:  Biomedicine       Date:  1976

8.  Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man.

Authors:  P W Muggleton; G H Prince; M L Hilton
Journal:  Lancet       Date:  1975-06-21       Impact factor: 79.321

9.  A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.

Authors:  E Robinson; A Bartal; Y Cohen; R Haasz
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.